Virtue Diagnostics, Alongside Its Subsidiary Labtest, Made an Impressive Debut at the 2023 AACC Virtue Diagnostics, Alongside Its Subsidiary Labtest, Made an Impressive Debut at the 2023 AACC Read Post »
Virtue Diagnostics Showcased QSight 420MD at the National Conference of Laboratory Medicine (NCLM) Virtue Diagnostics Showcased QSight 420MD at the National Conference of Laboratory Medicine (NCLM) Read Post »
Virtue Diagnostics Showcased Cutting-edge Clinical Mass Spectrometry Technology and Solution at the 2022 CACLP Virtue Diagnostics Showcased Cutting-edge Clinical Mass Spectrometry Technology and Solution at the 2022 CACLP Read Post »
Virtue Diagnostics Announced Acquisition of Labtest Diagnostics in Brazil Virtue Diagnostics Announced Acquisition of Labtest Diagnostics in Brazil Read Post »
Virtue Diagnostics Closes $100 million Series B Funding Virtue Diagnostics Closes $100 million Series B Funding Read Post »
